Financhill
Back

Dr. Reddy's Laboratories Ltd. 10K Form

Sell
28

RDY
Dr. Reddy's Laboratories Ltd.

Last Price:
$14.48
Seasonality Move:
1.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.9B
Cash Flow: $32.9M
Price / Cash Flow: 68.29
Annual Sales: $4.96
Price / Book: 2.91

Profitability

EPS (TTM): 0.77940
Net Income (TTM): $644.9M
Gross Margin: $2.1B
Return on Equity: 15.8%
Return on Assets: 10.66%

Dr. Reddy's Laboratories Ltd. Earnings Forecast

Key Dr. Reddy's Laboratories Ltd. Financial Ratios

  • The Gross Profit Margin over the past 32 years for RDY is 55.44%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 28.84% of Gross Profit Margin.
  • The Research & Development expenses have been 8.00% of Revenue.
  • The Interest Expense is 4.94% of Operating Income.
  • The Net Earning history of RDY is 17.58% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 14 years.

Dr. Reddy's Laboratories Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 1.88
Quick Ratio: 1.19

Price-to-Earnings

Trailing P/E Ratio: 18.07
Forward P/E Ratio: 25.61

RDY Technical Analysis vs Fundamental Analysis

Sell
28
Dr. Reddy's Laboratories Ltd. (RDY) is a Sell

Is Dr. Reddy's Laboratories Ltd. a Buy or a Sell?